missing translation for 'onlineSavingsMsg'
Learn More

AT7519 Hydrochloride, MedChemExpress

Product Code. 16457906
Encompass_Preferred
Change view
Click to view available options
Quantity:
5 mg
10 mg
50 mg
100 mg
Unit Size:
100mg
10mg
50mg
5mg
4 product options available for selection
Product selection table with 4 available options. Use arrow keys to navigate and Enter or Space to select.
Product Code. Quantity unitSize
16457906 100 mg 100mg
16420608 5 mg 5mg
16414067 50 mg 50mg
16408158 10 mg 10mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 4 options available.
4 options
This item is not returnable. View return policy
Product Code. 16457906 Supplier Medchem Express Supplier No. HY50943

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

MedChemExpress AT7519 Hydrochloride is a potent inhibitor of CDKs, with IC50s of 210, 47, 100, 13, 170, and <10 nM for CDK1, CDK2, CDK4 to CDK6, and CDK9, respectively.

AT7519 Hydrochloride is a potent inhibitor of CDKs, with IC50s of 210, 47, 100, 13, 170, and <10 nM for CDK1, CDK2, CDK4 to CDK6, and CDK9, respectively.

Specifications

Chemical Name or Material AT7519 Hydrochloride
CAS 902135-91-5
Color White
Purity Grade Notes Research
Molecular Formula C16H18Cl3N5O2
Quantity 100 mg
Solubility Information DMSO : ≥ 300 mg/mL (716.49 mM) ∣H2O : 8.33 mg/mL (19.89 mM; Need ultrasonic)
SMILES O=C(C(C(Cl)=CC=C1)=C1Cl)NC2=CNN=C2C(NC3CCNCC3)=O.[H]Cl
Molecular Weight (g/mol) 418.71
Formula Weight 418.71
Percent Purity 98.9%
Grade Research
Physical Form Solid
For Use With (Application) Cancer-Kinase/protease
Show More Show Less

Research purposes only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.